THU340 Efficacy And Safety Of Low-dose Spironolactone On Chronic Kidney Disease In Adults With Type 2 Diabetes: A Multicenter, Randomized Clinical Trial

Disclosure: A. Oiwa: None. D. Hiwatashi: None. T. Takeda: None. T. Miyamoto: None. I. Kawata: None. M. Koinuma: None. S. Kubota: None. S. Takayama: None. M. Yamazaki: None. M. Komatsu: None. Objective: To evaluate the albuminuria-lowering effect and safety regarding hyperkalemia of adding low-dose s...

Descripción completa

Detalles Bibliográficos
Autores principales: Oiwa, Ako, Hiwatashi, Dai, Takeda, Teiji, Miyamoto, Takahide, Kawata, Iori, Koinuma, Masayoshi, Kubota, Satoshi, Takayama, Shyouhei, Yamazaki, Masanori, Komatsu, Mitsuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554910/
http://dx.doi.org/10.1210/jendso/bvad114.773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554910/
http://dx.doi.org/10.1210/jendso/bvad114.773

Ejemplares similares